US Stock MarketDetailed Quotes

ACRS Aclaris Therapeutics

Watchlist
  • 1.180
  • +0.020+1.72%
Close Oct 11 16:00 ET
  • 1.180
  • 0.0000.00%
Post 20:01 ET
84.19MMarket Cap-1439P/E (TTM)

Aclaris Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Aclaris Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 8 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 2.168M--
--2024/Q3-- / 11.849M--
--2024/Q22.766M / 1.817M--
May 7, 20242024/Q12.398M / 1.929M--
--2023/Q417.570M / 5.051M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 2.168M--
--2024/Q3-- / 11.849M--
--2024/Q22.766M / 1.817M--
May 7, 20242024/Q12.398M / 1.929M--
--2023/Q417.570M / 5.051M--

Unlock Free Earnings Estimates

Aclaris Therapeutics Earnings Reports

  • Aclaris Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 7 22:20 ET

  • Aclaris Therapeutics | 10-Q: Q1 2024 Earnings Report

    May 7 16:39 ET

  • Aclaris Therapeutics | 10-K: FY2023 Annual Report

    Feb 27 07:35 ET

  • Aclaris Therapeutics | 10-Q: Q3 2023 Earnings Report

    Nov 6, 2023 07:30 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Sep 18, 2024

    Hold

    • Buy

      0.00%

    • Hold

      100.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data